'%2F%3E%3Cpath%20d%3D'M6.5%2025%2016%207%2025.5%2025'%20fill%3D'none'%20stroke%3D'%23fff'%20stroke-width%3D'3.8'%20stroke-linecap%3D'round'%20stroke-linejoin%3D'round'%2F%3E%3Ccircle%20cx%3D'16'%20cy%3D'19'%20r%3D'3.2'%20fill%3D'%23fff'%2F%3E%3C%2Fsvg%3E){kind=small}
Aspira Pathlab & Diagnostics L
ASPIRA (BSE 540788) · ISIN INE500C01017 · Healthcare Service Provider · Est. 1973 · listed 2017 · website
Not on any surveillance list
Quarterly results
No quarterly results stored for this company yet.
Balance sheet
| As of | Total equity | Borrowings | Total assets |
|---|---|---|---|
| 31 Mar 2026 standalone | ₹12.23 cr | ₹1.35 cr | ₹18.51 cr |
| 30 Sep 2025 standalone | ₹14.42 cr | ₹1.28 cr | ₹20.16 cr |
| 31 Mar 2025 standalone | ₹12.22 cr | ₹1.21 cr | ₹17.51 cr |
Shareholding
| Promoter | FII | DII | Public |
|---|---|---|---|
| 46.65% | — | — | 53.35% |
Latest filings
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 1 October 2026 · BSE
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 28 September 2026 · BSE
- Disclosure of Voting Results of 53rd Annual General Meeting along with the Scrutinizer Report 25 September 2026 · BSE
- Please find attached summary of proceeding /outcome of the 53rd Annual General Meeting of the Company held on Friday,25th September,2026 25 September 2026 · BSE
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Jay Arvind Bhanushali 16 September 2026 · BSE
Other companies in Healthcare Service Provider
- Dr. Lal Path Labs Ltd.
- Metropolis Healthcare Limited
- Thyrocare Technologies Limited
- Vijaya Diagnostic Centre Limited
- Krsnaa Diagnostics Limited
- One Global Service Provider Limited
- Nephrocare Health Services Limited
- Suraksha Diagnostic Limited
Figures as filed by the company with NSE and BSE; surveillance status from the exchanges' lists. Updated 29 October 2026.
Information and calculation tools by Rachid Asen. Not investment advice or research. Facts from company filings and the exchanges' lists, for information only; not a recommendation to buy, sell or hold. Verify with the exchange.